GPX4 (S)-9i
GPX4 (S)-9i is a GPX4 inhibitor and ferroptosis inducer, with its (R) enantiomer exhibiting stronger activity. GPX4 (S)-9i can be used for the study of fibrosarcoma.
For research use only. We do not sell to patients.
- CAS No.: 3104351-76-7
- Formula: C29H24N4O3S2
- Molecular Weight:540.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
GPX4 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-1080 | IC50 |
0.012 μM
Compound: (S)-9i
|
Cytotoxicity against human HT-1080 cells assessed as cell viability incubated for 24 hrs by CCK-8 assay
Cytotoxicity against human HT-1080 cells assessed as cell viability incubated for 24 hrs by CCK-8 assay
|
[PMID: 39884957] |
In Vitro
GPX4 (S)-9i (Compound (S)-9i) induces ferroptosis in HT1080 cells, with an IC50 of 0.012 μM and a ferroptosis selectivity index of 976[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3104351-76-7
-
Molecular Weight 540.66
-
Formula C29H24N4O3S2
-
SMILES
CC(C)(NC([C@@H](N(C(C1=CSC(C#C)=N1)=O)C2=CC=C(C3=CN=CO3)C=C2)C4=CSC5=CC=CC=C54)=O)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)